Combination therapies including cediranib well tolerated in patients with gastric cancer Jan. 24, 2011
Crizotinib suppresses osteosarcoma and associated osteolytic/osteoblastic changes in vivo Jan. 24, 2011
Masitinib mesilate prolongs survival of imatinib-naive subjects with advanced/metastatic GIST Jan. 21, 2011
RSS